$2.90
0.072.42%
At close: -
$2.95
0.051.77%
After Hours: Jan 16, 9:02 AM EDT
Comments
Loading...
Sunshine Biopharma (SBFM) Forecast
NewsEarningsSunshine Biopharma (SBFM) OptionsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestSunshine Biopharma (NASDAQ:SBFM) Stock Quotes, Forecast and News Summary
Sunshine Biopharma Stock (NASDAQ: SBFM) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Sunshine Biopharma (SBFM) stock?
You can purchase shares of Sunshine Biopharma (NASDAQ:SBFM) through any online brokerage.
Who are Sunshine Biopharma (SBFM) competitors?
Other companies in Sunshine Biopharma’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Alzamend Neuro (NASDAQ:ALZN), Galecto (NASDAQ:GLTO), Cellectar Biosciences (NASDAQ:CLRB) and Can Fite Biofarma (AMEX:CANF).
What is the forecast, or price target, for Sunshine Biopharma (SBFM) stock?
Sunshine Biopharma has a consensus price target of $15.00.
What is the current price for Sunshine Biopharma (SBFM)?
The stock price for Sunshine Biopharma (NASDAQ: SBFM) is $2.95 last updated January 16, 2025 at 9:02 AM EST.
Does Sunshine Biopharma (SBFM) pay a dividend?
There are no upcoming dividends for Sunshine Biopharma.
When is Sunshine Biopharma (NASDAQ:SBFM) reporting earnings?
Sunshine Biopharma’s Q4 earnings are confirmed for Thursday, March 27, 2025.
Is Sunshine Biopharma (SBFM) going to split?
There is no upcoming split for Sunshine Biopharma.
What sector and industry does Sunshine Biopharma (SBFM) operate in?
Sunshine Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.